Mammography Workstation Market Size, Share & Trends Analysis Report By Modality (Multimodal, Standalone), By Application (Diagnostic Screening, Advance Imaging), By End-use, By Region, And Segment Forecasts, 2020 - 2027
세계의 맘모그래피 워크스테이션 시장은 2020-2027년 7.0%의 CAGR로 계속 성장하며, 2027년에는 1억 9,850만 달러에 달할 것으로 예측되고 있습니다. 시장 확대의 원동력은 고령자 인구의 증가, 지속적인 기술의 진보, 각국 정부의 스크리닝 프로그램, 맘모그래피에 대한 인식의 향상 등의 요인입니다.
세계의 맘모그래피 워크스테이션 시장을 조사했으며, 시장의 전망, 모달리티별, 용도별, 최종사용자별, 지역별 추산과 동향, 경쟁 구도와 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 조사 방법과 범위
제2장 개요
제3장 시장 변동 요인, 동향, 범위
- 시장 계통적 전망
- 보급과 성장 전망
- 업계의 밸류체인 분석
- 시장 역학
- 시장 분석 툴
제4장 모달리티별 추산과 동향 분석
- 정의와 범위
- 시장 점유율
- 부문 대시보드
- 시장 전망
제5장 용도별 추산과 동향 분석
- 정의와 범위
- 시장 점유율
- 부문 대시보드
- 시장 전망
제6장 최종사용자별 추산과 동향 분석
- 정의와 범위
- 시장 점유율
- 부문 대시보드
- 시장 전망
제7장 국가별 추산과 동향 분석
- 시장 점유율 분석
- 시장 대시보드
- 시장 스냅숏
- 시장 점유율과 주요 기업
- SWOT 분석, 요인별(정치적 및 법적, 경제적 및 기술적)
- 시장 규모, 예측, 동향 분석
- 북미
- 유럽
- 아시아태평양
- 중남미
- 중동·아프리카
제8장 경쟁 구도
- 주요 기업의 최신 동향과 영향 분석
- 경쟁사 분류
- 벤더 각사의 세력도
KSA 20.10.20
Mammography Workstation Market Growth & Trends
The global mammography workstation market size is expected to reach USD 198.5 million by 2027, expanding at a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Rising geriatric population and continuous technological advancements are the factors driving the market. Increasing government screening programs and the rising awareness about mammography are the factors expected to boost the market during the forecast period. Technological advancements in the field of mastography workstations and the advent of artificial intelligence and machine learning are transforming the market.
Furthermore, rising research and development activities and an increasing number of product launches are also aiding market growth. Many players in the industry are focusing on the development of next-generation mastography workstations to resolve the challenge of overlapping tissue structure by producing the 3D volume of the breast. Furthermore, increasing investment by government and private players in the field of advanced mastography are also creating new avenues for growth.
The incidence rate of breast cancer is continuing to increase both in developing and developed countries. The demand for mastography diagnostic screening has increased substantially. According to the WHO, 627,000 women died of cancer in 2018 globally, which accounted for approximately 15.0% of all cancer deaths. Thus, the above-mentioned factors are expected to boost the market growth.
Mammography Workstation Market Report Highlights
North America captured the largest share in 2019 owing to technological advancement and the speedy FDA approval
The multimodal segment dominated the market in 2019 owing to high usage in hospitals and breast care centers
The diagnostic screening segment dominated the market in 2019 owing to increasing mastography screening tests
The hospitals segment dominated the market in 2019 owing to the rising number of breast screenings and the availability of advance devices in the hospitals
The breast care centers segment is expected to grow at the fastest pace during the forecast period owing to increasing awareness about these centers
Key players in the industry are focusing on the development of next-generation mammography workstation, which focuses on a wide area of radiology.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. By modality
- 1.1.2. By application
- 1.1.3. By end use
- 1.1.4. Country scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Modality
- 2.2.2. Application
- 2.2.3. End use
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Mammography Workstation Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Increasing number of breast cancer
- 3.4.1.2. Increasing number of product launches
- 3.4.1.3. Speedy FDA Approval
- 3.4.1.4. Increasing geriatric population
- 3.4.2. Market restraint analysis
- 3.4.2.1. High research and development costs
- 3.4.2.2. High device cost
- 3.5. Mammography Workstation Market Analysis Tools
- 3.5.1. Industry analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major deals & strategic alliances analysis
- 3.5.4. Market entry strategies
Chapter 4. Mammography Workstation Market: By Modality Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Multimodal
- 4.1.2. Standalone
- 4.2. Product Market Share, 2019 & 2027
- 4.3. Segment Dashboard
- 4.4. Mammography Workstation, by Modality Outlook
- 4.4.1. Multimodal
- 4.4.1.1. Multimodal market estimates and forecast, 2016 - 2027 (USD Million)
- 4.4.2. Standalone
- 4.4.2.1. Standalone estimates and forecast, 2016 - 2027 (USD Million)
Chapter 5. Mammography Workstation: By Application Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Diagnostic Screening
- 5.1.2. Advance imaging
- 5.1.3. Clinical Review
- 5.2. By Application Market Share, 2019 & 2027
- 5.3. Segment Dashboard
- 5.4. Mammography Workstation, by Application Outlook
- 5.4.1. Diagnostic screening
- 5.4.1.1. Diagnostic screening workstation market estimates and forecast, 2016 - 2027 (USD Million)
- 5.4.2. Advance imaging
- 5.4.2.1. Advance imaging market estimates and forecast, 2016 - 2027 (USD Million)
- 5.4.3. Clinical review
- 5.4.3.1. Clinical review market estimates and forecast, 2016 - 2027 (USD Million)
Chapter 6. Mammography Workstation: By End Use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Breast care centers
- 6.1.3. Academia
- 6.2. By End Use Market Share, 2019 & 2027
- 6.3. Segment Dashboard
- 6.4. Global Mammography Workstation Market, By End Use Outlook
- 6.4.1. Hospitals
- 6.4.1.1. Hospitals market estimates and forecast, 2016 - 2027 (USD Million)
- 6.4.2. Breast care centers
- 6.4.2.1. Breast care centers market estimates and forecast, 2016 - 2027 (USD Million)
- 6.4.3. Academia
- 6.4.3.1. Academia market estimates and forecast, 2016 - 2027 (USD Million)
Chapter 7. Mammography Workstation Market: Country Estimates & Trend Analysis
- 7.1. Country Market Share Analysis, 2019 & 2027
- 7.2. County Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2019
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- 7.5.1. North America
- 7.5.2. Europe
- 7.5.3. Asia Pacific
- 7.5.4. Latin America
- 7.5.5. Middle East and Africa
- 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
- 7.7. North America
- 7.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
- 7.7.2. U.S.
- 7.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (USD Million)
- 7.7.3. Canada
- 7.7.3.1. Canada market estimates and forecast, 2016 - 2027 (USD Million)
- 7.8. Europe
- 7.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
- 7.8.2. U.K.
- 7.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (USD Million)
- 7.8.3. Germany
- 7.8.3.1. Germany market estimates and forecast, 2016 - 2027 (USD Million)
- 7.8.4. France
- 7.8.4.1. France market estimates and forecast, 2016 - 2027 (USD Million)
- 7.8.5. Italy
- 7.8.5.1. Italy market estimates and forecast, 2016 - 2027 (USD Million)
- 7.8.6. Spain
- 7.8.6.1. Spain market estimates and forecast, 2016 - 2027 (USD Million)
- 7.9. Asia Pacific
- 7.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
- 7.9.2. Japan
- 7.9.2.1. Japan market estimates and forecast, 2016 - 2027 (USD Million)
- 7.9.3. China
- 7.9.3.1. China market estimates and forecast, 2016 - 2027 (USD Million)
- 7.9.4. India
- 7.9.4.1. India market estimates and forecast, 2016 - 2027 (USD Million)
- 7.9.5. South Korea
- 7.9.5.1. South Korea market estimates and forecast, 2016 - 2027 (USD Million)
- 7.9.6. Australia
- 7.9.6.1. Australia market estimates and forecast, 2016 - 2027 (USD Million)
- 7.10. Latin America
- 7.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
- 7.10.2. Brazil
- 7.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (USD Million)
- 7.10.3. Mexico
- 7.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (USD Million)
- 7.10.4. Argentina
- 7.10.4.1. Argentina market estimates and forecast, 2016 - 2027 (USD Million)
- 7.10.5. Colombia
- 7.10.5.1. Colombia market estimates and forecast, 2016 - 2027 (USD Million)
- 7.11. Middle East & Africa
- 7.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
- 7.11.2. South Africa
- 7.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (USD Million)
- 7.11.3. Saudi Arabia
- 7.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
- 7.11.4. UAE
- 7.11.4.1. UAE market estimates and forecast, 2016 - 2027 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2019
- 8.3.4. Fuji Film
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Hologic
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Philips Healthcare
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Siemens Healthcare
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Medtronic
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. GE Healthcare
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Planmed Oy
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Agfa-Gevaert NV
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
